Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

816 results about "Small intestine" patented technology

The small intestine or small bowel is an organ in the gastrointestinal tract where most of the end absorption of nutrients and minerals from food takes place. It lies between the stomach and large intestine, and receives bile and pancreatic juice through the pancreatic duct to aid in digestion.

High-activity lactobacillus rhamnosus probiotic microcapsule and application thereof

The invention relates to the technical field of biological medicines, and discloses a high-activity lactobacillus rhamnosus probiotic microcapsule, which comprises the following components in parts by weight: lactobacillus rhamnosus: each gram of formula contains 1010 CFU; bifidobacterium: each gram of the formula contains 109 CFU; 10% to 20% of sodium alginate; 5%-15% of chitosan; 3%-8% of hydroxypropyl methyl cellulose; 3%-7% of pectin; 5% to 10% of fructo-oligosaccharide; 5%-10% of inulin; 0.1%-0.5% of vitamin C; and 0.1%-0.3% of vitamin E. Through double-layer and three-layer embedding technologies (such as compound use of sodium alginate and chitosan and compound use of pectin and gelatin), the tolerance of the probiotics in gastric acid and bile environments is remarkably improved, the probiotics are effectively protected through a multi-layer embedding structure, the survival rate of the probiotics in the gastric environment reaches up to 90%, and the release rate in the small intestine exceeds 75%.
Owner:HENAN BUSINESS SCI RES INST

Probiotic microcapsule with function of improving intestinal microecology and key technology

The invention relates to the technical field of biological pharmacy, and discloses a probiotic microcapsule with a function of improving intestinal microecology, which comprises the following components in percentage by weight: lactobacillus rhamnosus: each gram of formula contains 1010 CFU of lactobacillus rhamnosus; lactobacillus acidophilus: each gram of the formula contains 109 CFU; clostridium butyricum: each gram of the formula contains 108 CFU; 5%-8% of a nano sodium alginate-chitosan compound; 3%-5% of peptide nanoparticles; 2%-4% of a natural polymer intelligent response film; 3%-6% of arabinoxylan oligosaccharide; 4%-7% of resistant dextran; 2%-4% of lentinan; and 0.1%-0.3% of resveratrol. Through a double-layer or three-layer embedding technology of the nano sodium alginate-chitosan compound and the intelligent response polymer film, the tolerance of the probiotics in gastric acid and cholate environments is remarkably enhanced, and targeted release of the probiotics in small intestines and colon is ensured.
Owner:HENAN BUSINESS SCI RES INST

Reagent combination or kit for constructing intestinal organs and application of reagent combination or kit

The invention belongs to the technical field of biology, and discloses a reagent combination or kit for constructing intestinal organs and application of the reagent combination or kit. According to the reagent combination or the kit, intestinal organs can be obtained from cell-derived epithelial cells obtained from a donor in a non-invasive manner, and the obtained intestinal organs can be cryopreserved and recovered and can be amplified in vitro for a long time; transcriptome characteristics are similar to those of real human small intestine tissues, and typical marker genes of various small intestine pedigree cell types are highly expressed; compared with intestinal organs obtained through induction of pluripotent stem cells, the intestinal organs have more intestinal pedigree characteristics, and the intestinal function development is more mature; after being promoted to be mature, the intestinal organ also highly expresses genes related to drug absorption and metabolism, has drug absorption capability similar to that of an immortalized intestinal cell line, but more prominently shows intestinal cell lineage characteristics, is closer to an intestinal environment in a real human body, and can be used for screening intestinal disease drugs; the intestinal barrier function is realized.
Owner:GUANGZHOU NAT LAB

Personalized in-vitro total digestion glycolysis simulation system

The invention discloses a personalized in-vitro total digestion glycolysis simulation system, and belongs to the technical field of in-vitro digestion simulation. According to the invention, by dynamically regulating and controlling the emptying amount and the flow velocity of digestive juice, the process of'digesting and absorbing at the same time 'in the small intestine is simulated, and the interaction of colon flora and colon organs is enhanced in combination with a micro-fluidic chip technology, so that the accurate detection of the digestion process and digestion products is realized. The digestion product simulated by the method disclosed by the invention and the flora structure are very close to the real in-vivo structure, so that the method has relatively high authenticity and credibility.
Owner:JIANGNAN UNIV

Method for simulating small intestine-colon dynamic digestion and glycolysis of polysaccharide-based food

The invention discloses a method for simulating small intestine-colon dynamic digestion and glycolysis of polysaccharide-based food, and belongs to the technical field of food detection. The small intestine-colon simulated digestion and absorption system special for the polysaccharide-based food comprises a small intestine digestion simulation system, a sampling and emptying system, a large intestine glycolysis simulation system and a central intelligent control and display system (a pH control system, a temperature control system, a stirring rate control system, a gas path system and a flow rate control system). Aiming at the limitations that an existing human gastrointestinal tract digestion in-vitro simulation system cannot be continuous, is short in period and the like, the in-vivo real digestion and glycolysis physiological environment and process are simulated, intestinal peristalsis waves and digestion and glycolysis of polysaccharide-based food are simulated, automatic sampling can be achieved, generation of glucose in small intestines can be detected on line, and the in-vitro simulation system fits the real human physiological environment.
Owner:JIANGNAN UNIV

Nano-liposome embedded with cod bone peptide calcium chelate and application of nano-liposome

The invention provides the nano-liposome for embedding the cod bone peptide calcium chelate, so that the digestion stability of the cod bone peptide calcium chelate is enhanced, targeted release of Ca < 2 + > in small intestines is facilitated, and the bioavailability of the cod bone peptide calcium chelate is further improved. The amino acid sequence of the cod bone calcium chelating active peptide is SSGPGGERGPp. The nano-liposome disclosed by the invention can ensure the structural integrity in the stomach to protect the cod bone peptide calcium chelate from being damaged, and can release the peptide calcium chelate in the intestinal digestion process, so that the digestion stability of the cod bone peptide calcium chelate is improved, and the targeted delivery of the cod bone peptide calcium chelate is realized.
Owner:OCEAN UNIV OF CHINA

Malus spectabilis flower and leaf tea and preparation method thereof

The invention belongs to the field of health-care tea preparation, and particularly relates to begonia flower and leaf tea and a preparation method thereof. Triticale bran pulp is mixed with smashed begonia leaves, the mixture is fermented through a flavor improving fermentation inoculant and then mixed with an anti-oxidation and excitation-inhibiting solution, and the prepared low-caffeine tea base material does not cause insomnia, has the characteristics of inhibiting inflammation and resisting oxidation, protects nerve cells from being damaged, and is suitable for being used as a health-care tea base material. The honeysuckle, the endive and the soybeans are ground into thick liquid, then mixed with the repair juice, centrifuged to remove precipitates, and then frozen nano spray drying is carried out, so that the obtained nano particles for protecting the liver and the kidney and promoting circulation are higher in stability and can accelerate absorption of small intestines; a taste regulator obtained by mixing grain mucus with tartaric acid, ethyl maltol, methyl anthranilate and sorbic acid is sprayed on the surface of a begonia flower and leaf tea mixture, and the prepared begonia flower and leaf tea does not affect sleep after being drunk, does not damage livers and kidneys in organisms, is good in taste and is easy to drink for a long time.
Owner:新疆玛禾生态农庄有限责任公司

Modified small intestinal submucosa as well as preparation method and application thereof

The invention provides a modified small intestinal submucosa which is a small intestinal submucosa grafted by methacrylic anhydride, and the grafting rate of the methacrylic anhydride is 40-90%. After cross-linking and curing, the modified small intestinal submucosa material provided by the invention has excellent biocompatibility, degradability and mechanical properties, can effectively promote revascularization and regulate immunoreaction, and has a wide application prospect as a tissue repair material.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV

Compound probiotic preparation rich in organic selenium and preparation method thereof

The invention relates to the field of biological agents, in particular to a compound probiotic preparation rich in organic selenium and a preparation method of the compound probiotic preparation, and efficient synergistic delivery is achieved through plant micromolecule organic selenium extraction and a multi-layer microemulsion embedding technology. The preparation consists of a core active component, a carrier system and a curcumin compound. The plant micromolecular organic selenium is extracted from cardamine hupingshanesis and high-selenium corn flour through an HLUP technology, and the bioavailability is remarkably improved. A corn protein modified W / O / W microemulsion is adopted as a carrier, an outer layer membrane is stable in an acid environment, and an inner layer accurately releases selenium to small intestines; a protective agent composed of trehalose and glucose inhibits ice crystal damage, and glutaraldehyde crosslinking enhances the mechanical strength of the membrane. Curcumin and selenium synergistically enhance antioxidant and immunomodulatory functions, and promote phagocytic activity of macrophages. The stability and bioavailability bottlenecks of a traditional preparation are broken through, and an innovative scheme is provided for functional food development.
Owner:安徽中志现代食品科技有限公司

Feed additive, feed, feeding method, selenium-enriched cow milk and obtaining method

The invention discloses a feed additive, feed, a feeding method and a selenium-enriched cow milk obtaining method. The feed additive comprises a core material and a coating film, the core material comprises a carrier and organic selenium, and the coating at least comprises a material which is stable in a rumen environment and has a swelling effect in a small intestine; the selenium content in the feed additive is 0.6 to 1.5 g / kg. According to the invention, cow milk with higher selenium content can be obtained under the condition that a smaller amount of organic selenium is added, the selenium content in the cow milk can be increased to 9ug / 100g or above, and the absorption and utilization rate of the organic selenium is remarkably increased.
Owner:INNER MONGOLIA MENGNIU DAIRY IND (GROUP) CO LTD

Lactobacillus-sourced extracellular vesicle and application thereof in prevention and treatment of necrotizing enterocolitis

The invention relates to the technical field of biological medicine, in particular to a lactobacillus-sourced extracellular vesicle and application of the lactobacillus-sourced extracellular vesicle in prevention and treatment of necrotizing enterocolitis, the extracellular vesicle is prepared from lactobacillus, the lactobacillus is Lactobacillus rhamnosus GG, the strain is purchased in the American Center for Type Culture Collection, and the preservation number is ATCC 53103. The preparation method of the extracellular vesicles comprises the following steps: carrying out ultracentrifugation on a lactobacillus culture solution, removing thalli, then collecting supernate, carrying out primary microfiltration, taking micro-filtrate, carrying out differential centrifugation, resuspending precipitates by using PBS, then carrying out secondary microfiltration, collecting the micro-filtrate, carrying out density gradient centrifugation, and collecting a 30-45% interface vesicle layer. The invention discloses a synergistic effect mode between intestinal symbiotic flora and intestinal epithelial cell metabolic molecules for the first time, and the discovery is expected to construct a brand-new mechanism normal form for regulating the host intestinal barrier function by flora.
Owner:DONGGUAN EIGHTH PEOPLES HOSPITALDONGGUAN CHILDRENS HOSPITAL

High-bioaccessibility calcium emulsifying and embedding system and preparation method thereof

The invention provides a preparation method of a calcium emulsifying and embedding system with high bioaccessibility, which comprises the following steps: S1) heating and mixing biomacromolecules and an emulsifier in water to obtain a water phase; the biomacromolecules are protein colloids and / or polysaccharide colloids; the method comprises the following steps: heating and mixing a calcium source substance and anhydrous cream to obtain an oil-solid phase; and S2) mixing the oil-solid phase with a water phase, and emulsifying to obtain the calcium emulsifying and embedding system. Compared with the prior art, the preparation method has the advantages that the natural macromolecular protein and / or polysaccharide with high nutritional value is used as a carrier, the calcium source substance is embedded through a water-oil-solid three-phase emulsification technology, and the preparation method is simple, easy to operate, low in cost and environmentally friendly; in addition, a water-oil-solid three-phase homogenized emulsion is created, the problem that the dispersion stability of milk mineral salt in a liquid food matrix is poor is effectively solved, release of free calcium ions in the small intestine environment can be promoted, and the calcium bioaccessibility is remarkably improved.
Owner:INNER MONGOLIA YILI IND GROUP CO LTD

Slow-release fat powder for pigs and preparation method thereof

The invention belongs to the technical field of feed additives, and particularly relates to slow-release fat powder for pigs and a preparation method of the slow-release fat powder. The slow-release fat powder for pigs comprises an intragastric adhesion-slow release layer, a small intestine forepart bile acid response controlled release layer and a small intestine posterior microbe response controlled release layer. The prepared slow-release fat powder for the pigs is good in stability, accurate release of different nutritional ingredients in different parts of gastrointestinal tracts of the pigs can be achieved, and powerful support is provided for sustainable development of the pig raising industry.
Owner:山东创脂生物科技有限公司

Xanthine oxidase inhibitory peptide derived from green and sweet tuna and application of xanthine oxidase inhibitory peptide

The invention relates to a xanthine oxidase inhibitory peptide derived from green and sweet tuna and application of the xanthine oxidase inhibitory peptide, and belongs to the technical field of polypeptides, and the amino acid sequence of the xanthine oxidase inhibitory peptide is Trp-Thr-Ala (WTA), Trp-Val-Pro (WVP), Trp-Leu-Pro (WLP) or Trp-Gly-Phe (WGF). The invention also provides an application of the inhibitory peptide as or in preparation of a xanthine oxidase inhibitor and an application of the inhibitory peptide as or in preparation of a medicine with an effect of inhibiting uric acid level. The invention also provides a xanthine oxidase inhibitor containing at least one inhibitory peptide or a composition or functional food for inhibiting uric acid. The selected inhibitory peptide is a novel food-borne XO inhibitory peptide, is good in water solubility, non-toxic and good in small intestine absorption and blood brain barrier permeability, has the potential of serving as a xanthine oxidase inhibitor and reducing the uric acid level, and can be used for preparing a medicine for preventing and treating hyperuricemia or serving as a functional food additive.
Owner:SANYA INST OF OCEANOGRAPHY OCEAN UNIV OF CHINA

Device and method for enhanced visualization of the small intestine

Methods of enhancing visualization of a body lumen. A device including a capsule endoscope and a plurality of struts attached thereto may be positioned into the body lumen. The plurality of struts of the device may self-expand within the body lumen from a constrained configuration to an expanded configuration in which the plurality of struts extend both radially and axially away from a camera lens of the capsule endoscope so as to form a frame around the camera lens in the expanded configuration. The camera lens may image through the frame into the body lumen. At least a portion of the frame or a material constraining the struts of the frame may dissolve to allow passage of the device from the body lumen.
Owner:NEPTUNE MEDICAL INC

Acellular matrix hydrogel microneedle with biological activity and preparation method thereof

The invention provides an extracellular matrix hydrogel microneedle with biological activity and a preparation method of the extracellular matrix hydrogel microneedle, and belongs to the technical field of medicines. The preparation method of the extracellular matrix hydrogel microneedle with biological activity comprises the following steps: carrying out ultrasonic treatment on methacrylated porcine small intestinal submucosa (SISMA) to prepare hydrogel, adding a photoinitiator into the prepared hydrogel, injecting into a microneedle mold, and concentrating and curing to obtain the extracellular matrix hydrogel microneedle. The hydrogel microneedle disclosed by the invention has good biological activity and better swelling property, and has a good prospect in biological medicine.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV

Lactococcus lactis subsp. Lactis VB346 capable of efficiently degrading purine and application thereof

The invention relates to the field of microorganisms, and discloses a Lactococcus lactis subsp. Lactis VB346 which is preserved in the China Center for Type Culture Collection on September 20, 2024, and the preservation number is CCTCC NO: M 20242013. The invention further discloses a preparation method of the Lactococcus lactis subsp. Lactis VB346. The lactococcus lactis subsp. Lactis VB346 disclosed by the invention has the capability of efficiently degrading purine nucleoside, and can decompose purine nucleoside in ingested food in intestinal tracts, so that the absorption amount of purine nucleoside by small intestines is reduced. The polypeptide has the ability of degrading bilirubin, and can be used for treating or improving hyperbilirubinemia, or improving liver and gall injury caused by hyperbilirubin; meanwhile, the acid resistance required by survival in the stomach, the cholate tolerance required by survival in the intestinal tract and the stable survival ability in the intestinal tract are achieved, and the bacillus subtilis has huge application prospects in preparation of drugs, microbial agents, health care products or food.
Owner:HANGZHOU VICROBX BIOTECH CO LTD

Embedded algae powder for dairy cow feed addition and dairy cow feed

The invention belongs to the field of dairy cow feed, and particularly relates to embedded algae powder for dairy cow feed addition and dairy cow feed, the embedded algae powder for dairy cow feed addition comprises core material particles and enteric coating layers coating the core material particles, and the mass ratio of the core material particles to enteric coating materials in the enteric coating layers is 10: (2-4); the core material particles comprise algae powder, a binder and an emulsifier. The enteric coating layer is dissolved in the small intestine to release the particles, the algae powder is dispersed in the particles under the action of the emulsifier and the binder, and the mass ratio of the core material particles to the enteric coating layer is controlled to be within the range. After the embedded algae powder is added into a dairy cow feed and reaches small intestines together with other feeds, the contained algae powder is released at a proper speed, so that the DHA absorption of the small intestines is greatly improved.
Owner:INNER MONGOLIA MENGNIU DAIRY IND (GROUP) CO LTD

Double-layer cross-linked artificial matrigel and application thereof in small intestine micro-physiological system

The invention discloses double-layer cross-linked artificial matrigel and an application method of the double-layer cross-linked artificial matrigel in a small intestine micro-physiological system. Low-concentration calcium ions are adopted for primary crosslinking to form a soft inner layer structure, and then high-concentration calcium ions are used for secondary crosslinking to improve the overall rigidity. The matrigel is used for dynamic culture of small intestine organoid and is combined with a micro-fluidic chip to form a small intestine micro-physiological system. In the system, the digestive absorption process of the small intestine is dynamically simulated by controlling the flow ratio and rate of digestive fluid and culture fluid. Compared with the traditional natural matrigel, the matrigel disclosed by the invention has more appropriate mechanical strength and structural stability, supports long-term growth of the organoids, and improves the multiplication capacity, tight connection and structural integrity of the organoids in an in-vitro environment. The method can be used for researching intestinal diseases, food digestion and drug absorption, and is an in-vitro digestion simulation platform with high biocompatibility and stability.
Owner:JIANGNAN UNIV

Preparation method and application of targeted colon delivery polyunsaturated fatty acid grease microcapsule

PendingCN120501232AAntipyreticDigestive systemLeguminGlucan
The invention belongs to the field of food processing, and discloses a preparation method and application of a targeted colon delivery polyunsaturated fatty acid grease microcapsule. 11S globulin in soybeans and Arabic gum are used as wall materials of the microcapsule, complex coacervation of the 11S globulin in the soybeans and the Arabic gum is induced under a certain pH condition, so that oil drops are wetted by a coacervate, a core-shell structure is formed, a coacervate phase is further stabilized through glucan to inhibit coalescence, and on the basis, the microcapsule is prepared. And tannic acid, polysaccharide and protein can form hydrogen bonds and generate hydrophobic interaction to further crosslink the condensed phase to obtain the microcapsule capable of resisting digestion of the stomach and the small intestine, so that colon delivery of polyunsaturated fatty acid is realized.
Owner:GUANGZHOU MEDICAL UNIV

Capsule medicament for endoscopic treatment of ulcerative colitis and preparation method thereof

The invention discloses a capsule medicament for endoscopic treatment of ulcerative colitis and a preparation method thereof, and belongs to the technical field of biological medicine, the capsule medicament is composed of a capsule matrix and a drug matrix; by adopting a dual control mechanism of an enteric layer coating and a pH response layer coating, accurate release of a medicine at a colon diseased region is ensured, medicine waste of the stomach and the small intestine is reduced, the medicine concentration at a focus is improved, mesalazine or budesonide is combined with the composite composition for treatment, inflammatory response is rapidly inhibited, acute symptoms are controlled, and the curative effect is good. A multi-mechanism synergistic treatment mode is adopted, the anti-inflammatory and repairing effects are enhanced, the clinical remission rate and the mucous membrane healing rate are remarkably improved, the pH response layer is dissolved in a colon alkaline environment, and the MMP-9 peptide cross-linking agent is subjected to enzymolysis at an inflammation part, so that the medicine is continuously released at a focus, the administration frequency is reduced, the compliance of a patient is improved, and the curative effect is good. In addition, the spherical gel particles in the medicament can prevent the medicament from being disintegrated too early in the intestinal tract, and the long-acting effect can be maintained.
Owner:XIEHE HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI & TECH UNIV

Pneumatic soft robot for assisting detection of enteroscope

ActiveCN119523390Acontact safetyAchieving painless access to the mirrorSurgeryEndoscopesPhysical medicine and rehabilitationSmall intestine
The pneumatic soft robot comprises a front air bag, a corrugated pipe and a rear air bag which are sequentially and coaxially connected, the front air bag, the corrugated pipe and the rear air bag are all provided with independent ventilation air paths, and the front air bag and the rear air bag can achieve radial volume expansion by means of inflation. Therefore, anchoring in the small intestine is achieved, and the corrugated pipe can stretch out and draw back in the axial direction by means of air inflation. Different from a previous intestinal tract detection pneumatic robot, the core idea of the invention is that the small intestine is dragged by using the pneumatic robot, the robot does not need to crawl in the small intestine, a traditional enteroscope outer sleeve operation mode can be replaced, and medical personnel can conveniently carry out related detection.
Owner:NANJING UNIV OF AERONAUTICS & ASTRONAUTICS

Preparation method of fattening and growth-promoting feed additive for ruminant animals

The invention relates to the technical field of feed additives, and discloses a ruminant animal fattening and growth-promoting feed additive which comprises the following components in percentage by mass: 22-28 parts of phytosterol, 42-48 parts of a rumen protection type amino acid compound, 11-14 parts of a compound probiotic preparation, 6-7.5 parts of a compound enzyme preparation, 9-11 parts of a trace element compound and 4-4.8 parts of a buffer system. According to the preparation method of the fattening and growth-promoting feed additive for ruminant animals, a modified hydrogenated palm oil and lecithin compound is used as a rumen protection type amino acid coating material, and a high-pressure homogenizer is used for performing multi-stage homogenizing treatment, so that a coating layer is more compact in structure, and the weight of the coating layer is increased; the rumen microorganism lipase decomposition resistance is enhanced through the synergistic effect of the composite material, particle distribution is optimized in combination with a refined homogenizing process, the release controllability and absorption efficiency of amino acid in small intestines are improved, and the problems that a traditional single coating material is easy to decompose and the particle size is extensively controlled are solved.
Owner:HEILONGJIANG LONGZE BIOTECHNOLOGY CO LTD

Lactobacillus rhamnosus YYSJ019 strain for relieving obesity and application of lactobacillus rhamnosus YYSJ019 strain

PendingCN120505235ABacteriaMetabolism disorderFat mouseHuman gastrointestinal tract
The invention relates to a lactobacillus rhamnosus YYSJ019 strain for relieving obesity and application of the lactobacillus rhamnosus YYSJ019 strain. The lactobacillus rhamnosus YYSJ019 strain is classified and named as lactobacillus rhamnosus, and the preservation number of the lactobacillus rhamnosus YYSJ019 strain is CGMCC (China General Microbiological Culture Collection Center) No.33472. The strain has good tolerance and high surface hydrophobicity in gastric juice, and has the potential of smoothly entering the gastrointestinal tract of a human body; the bacterial strain has excellent intestinal adhesion capability, and provides a basis for continuously playing a probiotic effect; the strain can slow down weight gain of obese mice and improve fat accumulation, liver injury and inflammation in bodies of the obese mice; the blood sugar metabolism capability and the blood fat metabolism capability can also be improved, and the potential of preventing and treating hyperglycemia or hyperlipidemia is achieved; in addition, a mouse small intestine endocrine cell line (STC-1 cell line) can be stimulated to generate the glucagon-like peptide-1, and the glucagon-like peptide-1 has the potential of improving diseases caused by insufficient secretion of the glucagon-like peptide-1; the effects of reducing uric acid in vitro and reducing uric acid in vivo are achieved, and the potential of preventing and treating hyperuricemia is achieved.
Owner:JIANGSU YIERSHIJIA HEALTH TECHNOLOGY CO LTD

Solid dispersion as well as preparation method and application thereof

The invention belongs to the technical field of medicines, and particularly provides a solid dispersion as well as a preparation method and application thereof. The solid dispersion comprises a carrier material, and further comprises quercetagetin and phospholipid, the mass ratio of the quercetagetin to the phospholipid is 1: (0.3-1.5), and the carrier material comprises one or more of a hydrophilic polymer and a pH-dependent polymer. Wherein the quercetagetin and the phospholipid are combined through an intermolecular force, so that the quercetagetin obtains a lipid material similar to a cell membrane structure, a cell membrane bionic phospholipid compound is formed, the cell membrane bionic phospholipid compound can be naturally compatible with an upper wall cell membrane of a small intestine, and the permeation transmembrane capability of the quercetagetin is better promoted; the quercetagetin is added into the solid dispersion, so that more quercetagetin can enter systemic circulation and lymphatic circulation, and therefore, the solid dispersion can strengthen transmembrane absorption while strengthening dissolution, so that the solid dispersion has high bioavailability.
Owner:CHENGUANG BIOTECH GRP CO LTD

Lactobacillus mucosa, composition and application

The invention belongs to the field of biology, and discloses lactobacillus mucosa which is preserved in China General Microbiological Culture Collection Center (CGMCC), the preservation number is CGMCC30899, and the preservation address is Institute of Microbiology, Chinese Academy of Sciences, No.3, No.1 Yard, Beichen West Road, Chaoyang District, Beijing. The lactobacillus is separated from small intestines of piglets, is one of main lactobacillus in digestive tracts of the piglets, and has certain cholate tolerance. The lactobacillus mucosa and the composition can promote the weight, the average daily gain and the weaning weight of 14-day-old suckling piglets by regulating the breast milk of the sows, promote the development of an ileum structure and the secretion of gastric mucus and gastric acid, regulate the 5-HT metabolism of intestinal tracts, and improve the immunity of the piglets. The expression of the HTR subtype in the stomach, the jejunum, the ileum and the colon is differentially regulated, and the indole level is increased by regulating tryptophan metabolism of microorganisms in the stomach, the ileum and the colon to play a role. Meanwhile, the invention further discloses application of the lactobacillus mucosa and the composition.
Owner:CHINA AGRI UNIV

Preparation method of immunoglobulin composite liposome nanoparticles with controlled release characteristic

The invention discloses a preparation method of immunoglobulin composite liposome nanoparticles with a controlled release characteristic, and belongs to the field of food nutrition and functional factors. Cholesterol and sitosterol are creatively used as auxiliary supports of a lecithin liposome skeleton, the stability of an immunoglobulin liposome nanoparticle structure is improved, the slow release property in the simulation effect process is improved, and a pH response type hydrogel film formed based on electrostatic crosslinking is prepared from calcium alginate and chitosan. A more stable double-layer shell-core structure is formed, so that the stability of embedded immune globulin molecules in gastric juice is further improved, and fixed-point slow release in small intestines is realized.
Owner:JIANGNAN UNIV

Composition for realizing oral absorption of polypeptide

The invention belongs to the field of biological medicines, particularly relates to an oral polypeptide composition system capable of being stably absorbed in gastrointestinal tracts, and particularly discloses an oral polypeptide composition which comprises polypeptide molecules (A), a surfactant (B) and an amino acid single-molecule or double-molecule combination (C), the molecular weight of the peptide medicine used as the medicine in the oral polypeptide composition is in the range of 0.1 kDa to 20 kDa. The acting part of the composition system is small intestine or large intestine; the stability and absorbability of the polypeptide composition in gastrointestinal tracts are obviously improved and enhanced.
Owner:SHENZHEN AOLI BIOTECHNOLOGY CO LTD

Composite hydrogel for tissue repair as well as preparation method and application thereof

The invention relates to composite hydrogel for tissue repair as well as a preparation method and application of the composite hydrogel. The composite hydrogel is prepared from a methacrylated acellular matrix, nano clay (LAP), a photoinitiator, carboxymethyl chitosan (CMCS) and water. The acellular matrix is modified through methylacryloylation, and a polymer network is reinforced by combining nano-clay, so that the mechanical strength is improved; and carboxymethyl chitosan adjusts the degradation rate, constructs a pore structure and endows antibacterial and anti-inflammatory functions. The preparation method comprises the following steps: dissolving the methacrylated acellular matrix in the PBS containing the photoinitiator, dissolving the carboxymethyl chitosan in ultrapure water, mixing, and carrying out illumination cross-linking curing. When the composite hydrogel is applied to small intestine tissue engineering, a small intestine defect part can be filled with the composite hydrogel, photo-crosslinking curing is performed to form a stent, the degradation period is matched with the small intestine regeneration period, and the antibacterial rate is gt; the cell toxicity is 0 level, a good microenvironment can be provided for cells, tissue repair can be promoted, and the compound can also be used for preparing pharmaceutical compositions for treating small intestine related diseases.
Owner:YICHU (HANGZHOU) MEDICAL TECHNOLOGY CO LTD

Medicine for treating or preventing chicken coccidiosis and chicken necrotic enteritis and application

PendingCN119792362AAntibacterial agentsDigestive systemCoccidiosisDisease
The invention belongs to the technical field of medicine, and particularly relates to a medicine for treating or preventing chicken coccidiosis and chicken necrotic enteritis and application, the medicine is chaulmoogratree seed, and can be in the form of medicinal material powder or chaulmoogratree seed extract. The traditional Chinese medicine composition can be used for preventing and treating chicken coccidiosis diseases, reducing the death rate of broilers with necrotic enteritis and intestinal lesions of necrotic enteritis, effectively improving chicken necrotic enteritis and has a good popularization and application prospect in the aspect of preventing and treating chicken necrotic enteritis diseases; the traditional Chinese medicine composition has a good treatment effect on mixed infection diseases of small intestine coccidiosis and clostridium.
Owner:BEIJING CENT BIOLOGY CO LTD +1